Endovascular Treatment of Medium Vessel Occlusion Stroke

Johanna M Ospel1,2, Thanh N Nguyen3, Ashutosh P Jadhav4

  • 1Department of Diagnostic Imaging (J.M.O., M.G.), Foothills Medical Centre, University of Calgary, AB, Canada.

Stroke
|January 18, 2024
PubMed

Insights

Medium vessel occlusion (MeVO) strokes are common and challenging to diagnose. This review explores MeVO detection, treatment considerations, and ongoing trials for endovascular treatment (EVT) in acute ischemic stroke.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Interventional Radiology

Background:

  • Medium vessel occlusion (MeVO) accounts for about one-third of acute ischemic strokes amenable to endovascular treatment (EVT).
  • Diagnosis and management of MeVO strokes present unique challenges, including detection difficulties and higher complication rates with EVT compared to large vessel occlusions.
  • The clinical outcomes of MeVO strokes treated with medical management, including intravenous thrombolysis, are less favorable than large vessel occlusions.

Purpose of the Study:

  • To review current definitions and imaging strategies for optimizing MeVO detection.
  • To discuss considerations for endovascular treatment (EVT) decision-making in MeVO stroke.
  • To provide an overview of ongoing randomized controlled trials evaluating EVT for MeVO.

Main Methods:

  • Literature review of MeVO definitions and diagnostic imaging techniques.
  • Analysis of clinical outcomes and complication rates associated with EVT for MeVO.
  • Summary of ongoing clinical trials investigating EVT efficacy in MeVO stroke.

Main Results:

  • MeVO detection remains a clinical challenge, often leading to underdiagnosis.
  • EVT for MeVO carries higher complication risks, necessitating careful benefit-risk assessment.
  • Robust data from ongoing trials are anticipated to guide evidence-based EVT decision-making for MeVO.

Conclusions:

  • Optimizing MeVO detection and refining EVT decision-making are crucial for improving patient outcomes.
  • Ongoing clinical trials are essential for establishing the efficacy and safety of EVT in MeVO stroke.
  • Further research is needed to address technical challenges and define optimal treatment paradigms for MeVO.